In which therapeutic areas are IgM antibodies most promising?

Oncology: Targeting tumor-associated antigens (TAAs) where high avidity and CDC-mediated killing are required.

Infectious Diseases: For rapid neutralization of viruses or bacteria, particularly those that require strong complement activation for clearance.

Autoimmunity: Using IgM to clear immune complexes or modulate B-cell responses.